The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) placed substantial pressure on global healthcare systems, biosafety management, and the delivery of safe clinical services. As a critical component of infection prevention and control (IPC), biosafety...
Zi-Xuan Gao, Shi-Yu Wang, Ya-Qin Zhang et al.· Frontiers in Health Services· 0 citations
The identification of a T cell receptor targeting a clinically relevant HBV epitope and ANKRD11 as a key epigenetic regulator of CD8+ T cell dysfunction in chronic infection and tumors position ANKRD11 as a promising immunotherapy target for chronic HBV infection and cancer.
Wei Xu, Jie Guo, Xue Cao et al.· Nature Immunology· 0 citations
This article systematically expounds the precise treatment strategies of glycyrrhizin preparations based on DILI classification, severity, and special populations, and elaborately analyzes their cutting-edge mechanisms of action such as regulation of the gut-liver axis and epigenetic modifications.
Di Qiu, Zi-Xuan Gao, Lu Zhang et al.· Frontiers in Pharmacology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.